Form 4: AngioDynamics Legal Officer Buys 10,000 Shares

AngioDynamics' SVP, Chief Legal Officer, Lawrence T. Weiss, acquired 10,000 shares of common stock at a weighted average price of $11.81.

Summary

• Lawrence T. Weiss, SVP, Chief Legal Officer of AngioDynamics Inc. (ANGO), purchased 10,000 shares of the company's common stock.
• The transaction occurred on October 21, 2025.
• The shares were acquired at a weighted average price of $11.81 per share, with prices ranging from $11.71 to $11.90.
• Following this transaction, Lawrence T. Weiss beneficially owns a total of 93,597 shares of AngioDynamics common stock.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant insider purchase by a senior executive, indicating strong confidence in the company's future.

Positives

• A senior officer, Lawrence T. Weiss, acquired 10,000 shares of common stock, signaling confidence in the company's future prospects.
• The purchase increases the officer's direct beneficial ownership to 93,597 shares, aligning management interests with shareholders.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance, but the insider purchase can be interpreted as a positive signal regarding management's outlook on the company's future performance.

Management Comments

• The action of Lawrence T. Weiss, SVP, Chief Legal Officer, purchasing 10,000 shares of common stock, implicitly conveys confidence in AngioDynamics' valuation and future prospects.

Industry Context

Insider buying, particularly by senior executives, is often viewed by the market as a positive indicator, suggesting that management believes the company's stock is undervalued or expects positive developments. This transaction aligns the executive's financial interests more closely with those of other shareholders.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, potentially increasing investor confidence and demand for the stock.
• The transaction aligns the financial interests of the SVP, Chief Legal Officer, more closely with those of other shareholders.

Key Dates

Recommendation

The significant purchase of common stock by a senior executive, Lawrence T. Weiss, signals strong insider confidence in AngioDynamics' future prospects and current valuation. Such insider buying often precedes positive company developments or indicates a belief that the stock is undervalued, making it a compelling 'buy' signal for seasoned investors.

Keywords

ANGIODYNAMICS, ANGO, Insider Buying, Stock Purchase, Form 4, Lawrence T. Weiss, Officer Transaction